Sources | Names Used |
---|---|
CTRPv2 | BRD-K30748066 |
PharmacoGx | BRD-K30748066 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POLE4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
mRNA | HTR3B | CTRPv2 | pan-cancer | AAC | 0.31 | 0.01 |
mRNA | WBSCR17 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.01 |
mRNA | SLITRK3 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
mRNA | ESPNL | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
mRNA | GABRB2 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
mRNA | FN1 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.01 |
mRNA | KIAA0100 | CTRPv2 | pan-cancer | AAC | 0.46 | 0.01 |
mRNA | ZNF169 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.01 |
mRNA | C1orf131 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |